{
  "questions": [
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39555889"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39555889",
          "text": "RankMHC: Learning to Rank Class-I Peptide-MHC Structural Models.. The binding of peptides to class-I Major Histocompability Complex (MHC) receptors and their subsequent recognition downstream by T-cell receptors are crucial processes for most mult...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": -0.49936922212186724,
          "rerank_position": 1
        }
      ],
      "id": "67d74cde18b1e36f2e00003c",
      "type": "summary",
      "body": "Describe RankMHC"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30919552",
        "http://www.ncbi.nlm.nih.gov/pubmed/33571895",
        "http://www.ncbi.nlm.nih.gov/pubmed/36348949",
        "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
        "http://www.ncbi.nlm.nih.gov/pubmed/32361272",
        "http://www.ncbi.nlm.nih.gov/pubmed/32104582",
        "http://www.ncbi.nlm.nih.gov/pubmed/31504112",
        "http://www.ncbi.nlm.nih.gov/pubmed/31614493",
        "http://www.ncbi.nlm.nih.gov/pubmed/33767867",
        "http://www.ncbi.nlm.nih.gov/pubmed/38403196"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30919552",
          "text": "Clinical implications of the genetics of sporadic colorectal cancer.. Colorectal cancer (CRC) is common and at least 80% of cases are sporadic, without any significant family history. Prognostication and treatment have been relatively empirical fo...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 30.193004275336964,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33571895",
          "text": "Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content.. A critical obstacle in the field of colorectal cancer (CRC) is the establishment of precise tumor subtypes to facilitate the development of targeted therape...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 27.90460116601505,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36348949",
          "text": "Molecular Analyses in Peritoneal Metastasis from Colorectal Cancer: A Review-An English Version.. Despite a trend showing continued improvement in survival by combing targeted agents in colorectal cancer, the improvement was limited, and clinicall...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 27.819097118383045,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
          "text": "Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision.. Background Colorectal cancer (CRC) is one of the most common types of cancer in the world. Metastatic disease is still incurable in most of these...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 27.3951371021908,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32361272",
          "text": "Assessing Cell Activities rather than Identities to Interpret Intra-Tumor Phenotypic Diversity and Its Dynamics.. Despite advances in single-cell and molecular techniques, it is still unclear how to best quantify phenotypic heterogeneity in cancer...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 25.31022264342463,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32104582",
          "text": "Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?. Following initial success in melanoma and lung tumours, immune checkpoint inhibitors (ICIs) are now well recognized...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 25.141335837296346,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31504112",
          "text": "Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.. BACKGROUND: It remains unknown to what extent consensus mole...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 24.440012122110705,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31614493",
          "text": "Human Colorectal Cancer from the Perspective of Mouse Models.. Colorectal cancer (CRC) is a heterogeneous disease that includes both hereditary and sporadic types of tumors. Tumor initiation and growth is driven by mutational or epigenetic changes...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 24.19377059375643,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33767867",
          "text": "Investigation of clinicopathological characters and gene expression features in colorectal signet-ring cell carcinoma utilizing CMS classification.. Signet ring cell carcinoma (SRCC) is a rare pathological type of colorectal cancer, of which the c...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 23.931995038224166,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38403196",
          "text": "Comprehensive RNA-sequencing analysis of colorectal cancer in a Korean cohort.. Considering the recent increase in the number of colorectal cancer (CRC) cases in South Korea, we aimed to clarify the molecular characteristics of CRC unique to the K...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 23.912880011538995,
          "rerank_position": 10
        }
      ],
      "id": "65f7741fc4010b4d78000027",
      "type": "factoid",
      "body": "What proportion of colorectal cancer cases are not assignable to any of the consensus molecular subtype (CMS) groups?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20235039",
        "http://www.ncbi.nlm.nih.gov/pubmed/30063020",
        "http://www.ncbi.nlm.nih.gov/pubmed/20939743",
        "http://www.ncbi.nlm.nih.gov/pubmed/32126313",
        "http://www.ncbi.nlm.nih.gov/pubmed/27416913",
        "http://www.ncbi.nlm.nih.gov/pubmed/29634153",
        "http://www.ncbi.nlm.nih.gov/pubmed/23321580",
        "http://www.ncbi.nlm.nih.gov/pubmed/38423706",
        "http://www.ncbi.nlm.nih.gov/pubmed/33396535",
        "http://www.ncbi.nlm.nih.gov/pubmed/25951512"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20235039",
          "text": "[Therapy for male patients with sexual dysfunction].. Phosphodiasterase type 5 inhibitors (sildenafil, vardenafil, tadalafil) are the first line symptomatic therapy for patients with erectile dysfunction. The patient should receive a meticolous in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 13.409486719174831,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30063020",
          "text": "[Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities].. At present, there is debate regarding the continuous use of phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction. Cum...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 9.50739732141517,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20939743",
          "text": "Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.. IMPORTANCE OF THE FIELD: Erectile dysfunction (ED) is a common sexual problem, affecting up to half of men over 50 years of age. Phosphodiesteras...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 9.464261593151821,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32126313",
          "text": "Skeletal restoration by phosphodiesterase 5 inhibitors in osteopenic mice: Evidence of osteoanabolic and osteoangiogenic effects of the drugs.. Phosphodiesterases (PDEs) hydrolyze cyclic nucleotides and thereby regulate diverse cellular functions....",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 9.406534039383393,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416913",
          "text": "Avanafil for the treatment of erectile dysfunction.. INTRODUCTION: Erectile dysfunction (ED) affects millions of men worldwide, and the incidence of ED will continue to increase as the aging population grows. The first generation of phosphodiester...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 9.34161514980359,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29634153",
          "text": "[Dosage forms of sildenafil in the management of erectile dysfunction].. The experience in the management of erectile dysfunction shows that taking even the most effective medications in tablet form may be inconvenient due to the need for natural ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 9.326893660612996,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321580",
          "text": "Avanafil, a highly selective phosphodiesterase type 5 inhibitor for erectile dysfunction, shows good safety profiles for retinal function and hemodynamics in anesthetized dogs.. PURPOSE: We evaluated the effects of the highly selective phosphodies...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 9.016682413224014,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38423706",
          "text": "Avanafil: A comprehensive drug profile.. Avanafil is an oral medication used to treat erectile dysfunction (ED). As a phosphodiesterase type 5 (PDE5) inhibitor, it functions by inhibiting the PDE5 enzyme, which ultimately results in increased leve...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 8.65981631465639,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33396535",
          "text": "Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats.. MicroRNAs (miRNAs) are short, non-coding RNA species that are important post-transcriptional regulators of gene e...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 8.610505801106218,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25951512",
          "text": "The characterization, current medications, and promising therapeutics targets for premature ejaculation.. Premature ejaculation (PE) is the most prevalent male sexual dysfunction. This is associated with negative personal and interpersonal psychol...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 8.590874172221113,
          "rerank_position": 10
        }
      ],
      "id": "67cc973e81b1027333000011",
      "type": "list",
      "body": "Please list the short half life Phosphodiesterase 5 inhibitors."
    }
  ]
}